PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION SUITABLE FOR REDUCING OR PREVENTING INCREASED THROMBOCYTE-AGGREGATION CAPABILITY

The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ing...

Full description

Saved in:
Bibliographic Details
Main Authors MARMAROSI,TAMASNE,HU, KAPUI,ZOLTAN,HU, HERMECZ,ISTVAN,HU, VASVARINE DEBRECZY,LELLE,HU, HORVATH,AGNES,HU, TARDOS,LASZLO,HU
Format Patent
LanguageEnglish
Published 30.11.1992
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ingredient for the manufacture of medicaments for use in the treatment or prevention of conditions resulting from increased thrombocyte - aggregatory activity as a consequence of decreased prostacyclin release.
AbstractList The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min -diethoxy-benzyl)-6,7-diethoxy-3,4-dihydro-isoquinoline or (3 min ,4 min -diethoxybenzyl)-6,7-diethoxy-3,4-dihydroisoquinolinium theophyllin-7-acetate or its monohydrate as active ingredient for the manufacture of medicaments for use in the treatment or prevention of conditions resulting from increased thrombocyte - aggregatory activity as a consequence of decreased prostacyclin release.
Author KAPUI,ZOLTAN,HU
VASVARINE DEBRECZY,LELLE,HU
MARMAROSI,TAMASNE,HU
HORVATH,AGNES,HU
HERMECZ,ISTVAN,HU
TARDOS,LASZLO,HU
Author_xml – fullname: MARMAROSI,TAMASNE,HU
– fullname: KAPUI,ZOLTAN,HU
– fullname: HERMECZ,ISTVAN,HU
– fullname: VASVARINE DEBRECZY,LELLE,HU
– fullname: HORVATH,AGNES,HU
– fullname: TARDOS,LASZLO,HU
BookMark eNqFjM0KgkAUhWdRi_5eIeYFhCgQWl6vV2dAZ2TmGrgSiWkVKtgL9OaVuG91zoHvO1ux6oc-bMS7chbJe5lZJ789rVGbXFYKXAlINWuEQqItK-s1a2ukrzVDUtBsOFqE2aYbGf4tbdAReEolK2fLxGLDFEGeO8phfkGoINGF5mYv1o_uOYXDkjtxzIhRRWEc2jCN3T304dWqmuPT9RzD5S_wAUGtPh8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 5
ExternalDocumentID HUT60926A
GroupedDBID EVB
ID FETCH-epo_espacenet_HUT60926A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:52:48 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HUT60926A3
Notes Application Number: HU19910001198
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19921130&DB=EPODOC&CC=HU&NR=T60926A
ParticipantIDs epo_espacenet_HUT60926A
PublicationCentury 1900
PublicationDate 19921130
PublicationDateYYYYMMDD 1992-11-30
PublicationDate_xml – month: 11
  year: 1992
  text: 19921130
  day: 30
PublicationDecade 1990
PublicationYear 1992
RelatedCompanies CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT.,HU
RelatedCompanies_xml – name: CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT.,HU
Score 2.4242644
Snippet The invention relates to the use of 1-(3 min ,4 min -dimethoxy-benzyl)-6,7-dimethoxy-isoquinoline or 1-(3 min ,4 min...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title PROCESS FOR PRODUCING PHARMACEUTICAL COMPOSITION SUITABLE FOR REDUCING OR PREVENTING INCREASED THROMBOCYTE-AGGREGATION CAPABILITY
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19921130&DB=EPODOC&locale=&CC=HU&NR=T60926A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwELZKQcAG5f2oPKBsEYE8mg4Rchw3CWoeSp2qnaomTRBLW9EgZv45FysFlm5-6Cz5rPM9fPcZoYcCjrnUzFzWihpUe6Eqspn3dDlXlaIsNTD4M5EgGxpeqr1O9EkLvW1rYQRO6JcARwSJykHeK3Ffr_-CWI7Irdw8Zu8wtHoZcMuRFk25GLgzqiI5tsXiyImoRKnlpVKYWNxQ-s8G2UP7YEP3alFgY7suSVn_1yeDE3QQw1LL6hS1imUHHdHtt2sddBg0r93QbARvc4a-4ySiwCsMThuGtpNSP3Rx7JEkIJSlvIY1wDQK4mjk11EnPEp9TuwhExQJawgENRuzkNc98OgTRkbMwdxLosCO6JQzmbhuwlwRu8KUxMT2hz6fnqPugHHqybCX2S_XZl7a7Fm9QO3lallcIfyUzbN-CRrezA1tbupzc9EDf6MGmVOLXO9fo8sdi9zsnLlFxyKFVcAh3qF29fFZ3IOirrKuYPIPCXqP4g
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV07T8MwELZKQZQNyvtRMqBsEYU8mg4Rchw3CeSl1KnoVDVpgljSigYx88-5WCmwdPNDZ8lnne_hu88I3eVwzIWiZ5KS16DaC7kv6dlAlTK5nxeFAgZ_yhNkA81JlOdX9bWF3ja1MBwn9IuDI4JEZSDvFb-vV39BLIvnVq7v03cYWj6NmGGJi6ZcDNwZuS9apkGj0AqJSIjhJGIQG0zrDx81vIN2wb4e1KJAJ2ZdkrL6r09Gh2gvgqXK6gi18rKLOmTz7VoX7fvNazc0G8FbH6PvKA4J8EoAp02AtpUQN7CFyMGxjwlNWA1rIJDQj8KxW0edhHHiMmx6lFPEtCHg1HRCA1b3wKOPKR5TS2BOHPpmSKaMSti2Y2rz2JVAcIRN13PZ9AT1RpQRR4K9zH65NnOSZs_yKWqXyzI_R8JDOk-HBWh4PdOUua7O9cUA-FGDzMl5pg4v0NmWRS63ztyijsN8b-a5wcsVOuDprBwa8Rq1q4_P_AaUdpX2OMN_APYPktU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PROCESS+FOR+PRODUCING+PHARMACEUTICAL+COMPOSITION+SUITABLE+FOR+REDUCING+OR+PREVENTING+INCREASED+THROMBOCYTE-AGGREGATION+CAPABILITY&rft.inventor=MARMAROSI%2CTAMASNE%2CHU&rft.inventor=KAPUI%2CZOLTAN%2CHU&rft.inventor=HERMECZ%2CISTVAN%2CHU&rft.inventor=VASVARINE+DEBRECZY%2CLELLE%2CHU&rft.inventor=HORVATH%2CAGNES%2CHU&rft.inventor=TARDOS%2CLASZLO%2CHU&rft.date=1992-11-30&rft.externalDBID=A&rft.externalDocID=HUT60926A